Resource Library
|
|
|
|||||||||
|
Powered by:
This information is provided by an independent source. Merck & Co., Inc. is not responsible for this content. Please discuss any and all treatment options with your healthcare professional. The manufacturer of a product generally has the most complete information about that product.
Multiple endocrine neoplasia (MEN) IDefinitionMultiple endocrine neoplasia (MEN) I is an inherited disorder in which one or more of the endocrine glands are overactive or form a tumor. Endocrine glands most commonly involved include:
Alternative NamesWermer syndrome; MEN I CausesMEN I is caused by a defect in a gene called RET. The condition causes tumors of various glands to appear in the same person, but not necessarily at the same time. The disorder may occur at any age, and it affects men and women equally. Risk factors for MEN I include:
SymptomsSymptoms vary from person to person, and may include:
Exams and TestsSigns may include:
Tests to diagnose MEN I may include:
TreatmentThis version of the Encyclopedia has no treatment information. Please discuss any and all treatment options for your condition with your healthcare professional. Outlook (Prognosis)Pituitary and parathyroid tumors are usually noncancerous (benign), but some pancreatic tumors may become cancerous (malignant) and spread to the liver. These can lower life expectancy. The symptoms of peptic ulcer disease, low blood sugar, excess calcium in the blood, and pituitary dysfunction usually respond well to treatment. Possible ComplicationsRecurrent tumors may develop. When to Contact a Medical ProfessionalCall your health care provider if you notice symptoms of MEN I. PreventionScreening close relatives of people affected with this disorder is recommended. ReferencesKronenberg HM. Polyglandular disorders. in: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 250.
Review Date:
9/4/2008 Reviewed By: Sean O. Stitham, MD, private practice in Internal Medicine, Seattle, Washington; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
|
||||||||||









